AU Patent

AU2015231226B2 — Antifungal compound process

Assigned to Mycovia Pharmaceuticals Inc · Expires 2019-04-04 · 7y expired

What this patent protects

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 and substituted derivatives thereof.

USPTO Abstract

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 and substituted derivatives thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015231226B2
Jurisdiction
AU
Classification
—
Expires
2019-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Mycovia Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.